IMPORTANCE Few tools exist for assessing the risk for early atherosclerotic cardiovascular disease (ASCVD) events in young adults.
M ortality rates associated with atherosclerotic cardiovascular disease (ASCVD) have steadily declined in past decades owing to advances in prevention, detection, and treatment. 1 Unfortunately, scientists caution this trend may soon reverse owing to increasing obesity rates and unhealthy diet and exercise patterns in younger individuals. 2 Adolescents and young adults are a prime target for ASCVD prevention efforts, 3, 4 especially because most do not yet have major clinical risk factors for ASCVD, such as hypertension, hyperlipidemia, and diabetes. 1 Often termed primordial prevention, such efforts to prevent the development of these clinical risk factors through healthy behaviors hold promise for reducing ASCVD events across the life course. 5 Decades of epidemiologic research have demonstrated that adults who maintain optimal levels of traditional ASCVD risk factors over time have low rates of ASCVD. [6] [7] [8] Furthermore, restoration of low risk is difficult after these clinical risk factors develop, even with efficacious pharmacologic treatment. 9 Although numerous risk calculators exist to estimate the future risk for ASCVD among individuals and populations, 10 few are validated for use in adults younger than 30 years of age. Even fewer focus on the behavioral factors (diet, exercise, tobacco exposure, and weight status) that are key for primordial prevention and most likely to need improvement in this age group. One promising lifestyle-based tool to estimate ASCVD risk is the Healthy Heart Score (HHS). 11 Chiuve et al 11 developed the HHS for middle-aged adults for whom the shortterm risk for ASCVD is low but the long-term risk is high. 12, 13 A range of health behaviors known to affect the development of ASCVD risk factors were considered in the development of the tool. Derived and validated in adults aged 40 to 75 years at the time of lifestyle factor measurement, the HHS demonstrated good discrimination (C statistic, 0.72 in men and 0.77 in women) and calibration for predicting ASCVD events during 24 years of follow-up, especially for individuals without elevated blood pressure or cholesterol levels at baseline. 8 The ability of the HHS to estimate ASCVD events in individuals without established clinical risk factors makes it an attractive tool for estimating early ASCVD events in young adults. The present study aimed to assess the performance of the HHS for estimating ASCVD events occurring before 55 years of age in a population of young adults aged 18 to 30 years at the time of lifestyle factor measurement.
Methods

Study Sample
The Coronary Artery Risk Development in Young Adults (CARDIA) study is a population-based longitudinal cohort begun with baseline collection of data from March 25, 1985, through June 7, 1986 , with 5115 young adults aged 18 to 30 years from 4 sites across the United States (University of Alabama at Birmingham; Northwestern University, Chicago, Illinois; University of Minnesota, Minneapolis; and Kaiser Permanente of Oakland, California).
14 Participants were selected to include approximately equal distribution by sex, self-identified race (black or white), educational attainment (high school graduate or beyond), and age (18-24 or 25-30 years). Participants were contacted for follow-up every 6 months and queried regarding interim medical events annually. For the current analyses, participants missing data required to complete the HHS at baseline or who were pregnant at the baseline examination were excluded, for a final sample of 4893 individuals (95.7% of the original cohort). The CARDIA study has been continuously approved by the institutional review boards at each of the 4 sites, and all participants provided written informed consent to participate.
Healthy Heart Score
Chiuve et al 11 developed the HHS using data from 61 025 women in the Nurses' Health Study (NHS) and 34 478 men in the Health Professionals Follow-up Study (HPFS) who did not have ASCVD, cancer, or diabetes at the time of baseline ascertainment of health habits in 1986. The mean (SD) age for women and men at baseline was 52 (7) and 52 (9) years; women were followed up for a median of 23.9 years (interquartile range, 0.24 years) and men for a median of 23.7 years (interquartile range, 0.28 years). To derive the most parsimonious model to best estimate 20-year risk for ischemic ASCVD events (nonfatal myocardial infarction, fatal coronary heart disease, and ischemic stroke, all verified through medical record review), the investigators considered a variety of health behaviors previously shown to be associated with ASCVD in the literature. The final sex-specific score included age (in years), smoking status (past, current, or never), body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared), exercise (hours per week), alcohol consumption (grams per day), and a diet score consisting of cereal fiber consumption (grams per day) and servings of fruits and/or vegetables, nuts, sugarsweetened beverages, and red and/or processed meats (servings per day) (eFigure 1 in the Supplement 16 Cereal fiber data were not available in CARDIA; therefore, we used grams per day of fiber intake from whole grain foods as a surrogate because correlations between whole grain and cereal fiber were high in the original cohorts from which the HHS was derived. 17 Cigarette smoking, age, sex, and race were self-reported via questionnaire.
Assessment of Clinical ASCVD Risk Factors and ASCVD Events
We defined the presence of clinical ASCVD risk factors at the baseline examination as any hypertension (measured blood pressure, ≥140/90 mm Hg or use of blood pressure-lowering medication), hyperlipidemia (total cholesterol level ≥240 mg/dL [to convert to millimoles per liter, multiply by 0.0259] or use of medication to lower lipid levels), or diabetes (fasting glucose level ≥126 mg/dL [to convert to millimoles per liter, multiply by 0.0555] or self-reported diabetes). Blood pressure was measured after 5 minutes of rest in the seated position using a random zero sphygmomanometer; the means of the second and third systolic and fifthphase diastolic recordings were used. 18 After a 12-hour fast, total cholesterol and glucose levels were measured using standard methods. 18 Participants self-reported medication use and clinical history of diabetes. We defined the outcome of ASCVD events as any death due to coronary heart disease, nonfatal myocardial infarction, and fatal or nonfatal ischemic stroke. Participants were asked about hospitalizations during annual telephone interviews, and deaths were reported by participants' next-of-kin every 6 months. 19 Reported events were validated through medical record review from year 15 onward and adjudicated by 2 members of the morbidity and mortality committee using standard definitions.
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Statistical Analysis
Data were analyzed from February 24 through December 6, 2016. We estimated the 25-year risk for ASCVD using Cox proportional hazards models. The HHS was calculated using the original coefficients from the HHS derivation cohorts first, then with CARDIA cohort-specific coefficients in a secondary analysis. Proportional hazard assumptions were found to be appropriate. We evaluated the predictive utility of the HHS in the CARDIA sample based on discrimination and calibration of the model for the full study sample, then separately for men and women, for white and black participants, and for those with and without risk factors. Discrimination assesses the ability of the model to differentiate those with and without events and was evaluated using the Harrell C statistic; larger values indicate better discrimination. We compared the discrimination of models incorporating the HHS score with models including age only. We assessed calibration using plots comparing the estimated probabilities of ASCVD with the observed event rates. We used the Greenwood-Nam-D'Agostino statistic to evaluate goodness of fit of the models. All analyses were conducted using SAS software (version 9.2; SAS Institute Inc).
Results
Baseline characteristics of the 4893 individuals included in the sample are displayed in Table 1 . Mean (SD) age at ascertainment of the HHS was 24.8 (3.6) years; 2688 participants (54.9%) were women; 2205 (45.1%) were men; 2483 (50.7%) were black; and 427 (8.7%) had at least 1 clinical ASCVD risk factor (hypertension, hyperlipidemia, or diabetes) at baseline. CARDIA participants were a mean of 27 years younger than participants in the NHS and HPFS cohorts in which the HHS was derived and thus had lower mean HHS scores ( Table 2) . CARDIA participants had slightly lower mean BMI levels and better exercise habits compared with NHS and HPFS participants but poorer diet quality and greater frequency of smoking. During a median follow up of 27.1 years (interquartile range, 26.9-27.2 years), 69 total ASCVD events occurred in 64 women (31 coronary heart disease events [1.2% of female participants] and 38 ischemic stroke events [1.4% of female participants]) and 104 total ASCVD events occurred in 99 men (75 coronary heart disease events [3.4% of male participants] and 29 ischemic stroke events [1.3% of male participants]). The incidence of ASCVD per 1000 person-years was 0.90 for women and 1.75 for men. ASCVD events occurred at a mean age of 45.9 years (range, 28.0-58.8 years). Most cases (121 of 163 [74.2%]) occurred in participants with no clinical ASCVD risk factors at the baseline examination, although participants who later had an ASCVD event had higher mean systolic and diastolic blood pressures and fasting glucose and total cholesterol levels in young adulthood compared with those who did not (eTable in the Supplement). Participants who experienced an ASCVD event had on average unhealthier levels of all HHS variables in young adulthood (eTable in the Supplement).
The discrimination of the HHS was moderate in the CARDIA study. Compared with the model with age only, the HHS score increased the C statistic from 0.63 (95% CI, 0.59-0.68) to 0.71 (95% CI, 0.66-0.76). Furthermore, the HHS increased the C statistic compared with models based on age alone for all subgroups ( Table 3) . We further compared model discrimination across subgroups. The model performed better in white vs black participants (C statistic difference, 0.11; 95% CI, 0.02-0.20) and somewhat better in men vs women (C statistic difference, 0.05; 95% CI, −0.03 to 0.13) and in the absence vs presence of clinical risk factors at baseline (C statistic difference, 0.08; 95% CI, −0.03 to 0.19). Model discrimination was weakest for those with at least 1 clinical ASCVD risk factor at baseline (C statistic, 0.64; 95% CI, 0.55-0.73). Application of cohort-specific coefficients for the lifestyle factors improved model discrimination slightly (Table 3) . The Greenwood-Nam-D'Agostino statistic suggested adequate fit of the HHS model for the total population and for all subgroups ( Table 3 ). The HHS model was overall well calibrated for 25-year ASCVD risk assessment based on the calibration plots for the total population (C statistic, 0.71; 95% CI, 0.66-0.76) (Figure) and all subgroups (eFigure 2 in the Supplement).
Discussion
In this population of healthy young adults with low rates of traditional clinical ASCVD risk factors similar to rates seen in nationally representative samples of the same age group, 1 the HHS performed moderately well at estimating 25-year risk for early ASCVD events. The C statistics for the HHS in the total population, for white participants, and for men are similar to those seen in the original derivation cohorts. 8 They also ap- The major strength of the HHS lies in its reliance on lifestyle factors, including BMI, smoking, alcohol intake, physical activity, and dietary patterns, all of which can easily be selfreported. Practicing physicians could choose to have patients complete the HHS in advance of a visit at home or in the waiting area and use the resulting report to begin a patientcentered discussion of ways to improve cardiovascular health and prevent early ASCVD. The HHS could also be used to educate young persons about their ASCVD risk at communitybased public health outreach events or online through websites and social media. This outreach could be coupled with health promotion materials or individually tailored action plans targeting healthy behavior change, as well as encouragement to follow up with a primary care physician for additional blood pressure, cholesterol level, and diabetes screening as needed. Lack of awareness of cardiovascular risk factors among young adults is well documented, 26 and this age group is also the most likely to forego routine primary care. 27 Whether and how a risk estimation tool such as the HHS can be used to motivate young persons to seek regular primary care and lower their risk for ASCVD through behavior change remains an area for future research. Previous studies in the CARDIA cohort have found that participants who adopted healthy lifestyle factors after young adulthood had lower odds of subclinical atherosclerosis 28 and a higher prevalence of the low cardiovascular risk profile 29 in middle age compared with participants who did not demonstrate behavior change. In older adults, the HHS estimates ASCVD events and the antecedent clinical risk factors of hypertension, hyperlipidemia, and diabetes. 30 The prevention of these risk factors through sustained healthy lifestyle behaviors is a viable strategy for reducing ASCVD morbidity and mortality. Because few individuals retain the full constellation of healthy behaviors and absence of clinical risk factors identified by the American Heart Association as ideal cardiovascular health, 1 individual and population strategies are needed to increase the HHS of young adults worldwide.
Limitations
Study limitations should be noted. Healthy Heart Score variables other than BMI were self-reported and are subject to measurement error and desirability bias. We used modified dietary variables (substituting whole grain for cereal fiber) and physical activity variables (calculating total hours per week from more general estimates of exercise habits). In general, these limitations most likely improved the HHS score of CARDIA participants, thus underestimating the risk for ASCVD events. Vital status data were not available for 307 individuals (6.0%); censoring these individuals before the full 25 years of follow-up also likely underestimates the performance of the models. Other factors such as family history of early ASCVD, illicit drug use, or pregnancy-related complications may be important in the pathogenesis of ASCVD events in younger persons; because our goal was to validate the previously published HHS, we did not investigate the role of these potential factors. Finally, health behaviors were ascertained and the HHS was calculated at only 1 point. 8.1% HHS=Healthy Heart Score; BMI=body mass index; ASCVD=cardiovascular disease; SBP=systolic blood pressure; DBP=diastolic blood pressure. Mean (SD) provided for continuous variables; n (%) provided for categorical variables. ASCVD risk factors = measured blood pressure ≥140/90 mmHg, total cholesterol ≥240 mg/dL, fasting glucose ≥126 mg/dL, use of medication for hypertension or hyperlipidemia, or self-reported diabetes
